Cabot Corp: Form 10-Q for the period ended Mar 31, 2023
Filed with the SEC on May 9, 2023 and accepted by EDGAR at May 9, 2023, 14:44 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-01-01 to 2023-03-31 | $1.03bn | us-gaap:Revenues |
| Revenue | 6 months2022-10-01 to 2023-03-31 | $2.00bn | us-gaap:Revenues |
| Cost of revenue | 3 months2023-01-01 to 2023-03-31 | $823.0m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2022-10-01 to 2023-03-31 | $1.61bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2023-01-01 to 2023-03-31 | $210.0m | us-gaap:GrossProfit |
| Gross profit | 6 months2022-10-01 to 2023-03-31 | $391.0m | us-gaap:GrossProfit |
| Research and development | 3 months2023-01-01 to 2023-03-31 | $15.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2022-10-01 to 2023-03-31 | $28.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2023-01-01 to 2023-03-31 | $66.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2022-10-01 to 2023-03-31 | $126.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-01-01 to 2023-03-31 | $129.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2022-10-01 to 2023-03-31 | $234.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-01-01 to 2023-03-31 | $23.0m | us-gaap:InterestExpense |
| Interest expense | 6 months2022-10-01 to 2023-03-31 | $45.0m | us-gaap:InterestExpense |
| Income tax | 3 months2023-01-01 to 2023-03-31 | $29.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2022-10-01 to 2023-03-31 | $49.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-01-01 to 2023-03-31 | $75.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2022-10-01 to 2023-03-31 | $129.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-01-01 to 2023-03-31 | $1.29 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2022-10-01 to 2023-03-31 | $2.23 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-01-01 to 2023-03-31 | $1.31 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2022-10-01 to 2023-03-31 | $2.24 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-01-01 to 2023-03-31 | 56,800,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2022-10-01 to 2023-03-31 | 56,700,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2022-10-01 to 2023-03-31 | $214.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2022-10-01 to 2023-03-31 | $86.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2022-10-01 to 2023-03-31 | $42.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months2022-10-01 to 2023-03-31 | $33.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-03-31 | $205.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-03-31 | $1.74bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-03-31 | $3.52bn | us-gaap:Assets |
| Current liabilities | At period end2023-03-31 | $904.0m | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2023-03-31 | $1.09bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2023-03-31 | $8.0m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | At period end2023-03-31 | $258.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2023-03-31 | $1.10bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950170-23-019483. Last ingested by Listed: Nov 2, 2026, 19:45 ET. Listed shows no prices and gives no investment advice.